Overview
Essity AB, based in Sweden, operates predominantly in the global hygiene and health industry. The company specializes in producing and distributing a wide array of products including personal care items, professional hygiene solutions, and medical supplies. Essity’s commitment to sustainability and innovation is evident in its development of high-quality, eco-friendly products intended to improve well-being and reduce environmental impact. Key projects involve advancing recycling technologies, enhancing the sustainability of sourcing materials, and implementing cutting-edge health solutions that span from advanced wound care to incontinence products. This focus supports Essity's strategic drive toward leading market positions in several categories across both mature and emerging markets, fostering growth and resilience in its operational model.
AI+ Ask Fintel’s AI assistant about Essity AB (publ).
Thinking about good questions…
Basic Stats
The share price of Essity AB (publ) as of 1 September 2025 is 254,50 kr / share. This is a decrease of -0.39% from the prior week. The market cap (or net worth) of Essity AB (publ) as of 1 September 2025 is 175 796,81 kr MM.
The Factor Analysis chart (below right) shows a view of Essity AB (publ) from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 175,796.81 MM |
| EV | 212,896.17 MM |
| Shares Out. | 689.76 MM |
| Earnings Date | |
| EPS (TTM) | 17.82 |
| Dividend Yield | 3.24 % |
| Ex-Dividend Date | 2025-03-28 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -18.04 % |
| Volatility (1 yr) | 0.19 |
| Beta | 0.13 |
| Sharpe Ratio (1 yr) | -1.15 |
| Sortino Ratio (1 yr) | -1.66 |
| PE Ratio | 14.24 |
| Price/Book | 2.16 |
| Price/TBV | 7.39 |
| Book/Market | 0.46 |
| EBIT/EV | 0.08 |
| EBIT(3yr avg)/EV | 0.07 |
| ROA | 0.07 |
| ROE | 0.15 |
| ROIC | 0.10 |
| CROIC | -0.05 |
| OCROIC | 0.12 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 67.32 /100 |
| Profitability | 55.56 /100 |
| Quality Score | 62.49 /100 |
| Value Score | 75.28 /100 |
| Momentum Score | 32.04 /100 |
| Stability (Low Vol) Score | |
| Analyst Sentiment | 51.98 /100 |
| Fund Sentiment | 35.20 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | 59.31 /100 |
| QVM Score | |
| Piotroski F-SCORE | 9.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Essity AB (publ) is 303,87 kr. The forecasts range from a low of 231,94 kr to a high of 356,44 kr. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Essity AB (publ). An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-10-31 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
| 2023-10-27 | DNB MARKETS | Buy | Buy | Maintains |
| 2023-10-17 | JYSKE BANK | Hold | Buy | Upgrade |
| 2023-08-28 | HSBC | Buy | Buy | Maintains |
| 2023-08-27 | HSBC | Buy | Buy | Maintains |
| 2023-08-23 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
| 2023-08-22 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
| 2023-07-21 | DNB MARKETS | Buy | Buy | Maintains |
| 2023-07-21 | BERENBERG | Hold | Hold | Maintains |
| 2023-07-20 | DNB MARKETS | Buy | Buy | Maintains |
| 2023-07-20 | BERENBERG | Hold | Hold | Maintains |
| 2023-07-20 | CREDIT SUISSE - EUROPE | Outperform | Outperform | Maintains |
| 2023-07-19 | CREDIT SUISSE - EUROPE | Outperform | Outperform | Maintains |
| 2023-06-16 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-06-15 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-05-24 | BNP PARIBAS EXANE | Neutral | Outperform | Upgrade |
| 2023-05-23 | BNP PARIBAS EXANE | Neutral | Outperform | Upgrade |
| 2023-05-22 | HSBC | Hold | Buy | Upgrade |
| 2023-05-21 | HSBC | Hold | Buy | Upgrade |
| 2023-05-11 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
| 2023-05-10 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
| 2023-05-09 | BERENBERG | Buy | Hold | Downgrade |
| 2023-05-08 | BERENBERG | Buy | Hold | Downgrade |
| 2023-05-02 | JYSKE BANK | Buy | Hold | Downgrade |
| 2023-05-01 | JYSKE BANK | Buy | Hold | Downgrade |
| 2023-04-28 | DNB MARKETS | Hold | Buy | Upgrade |
| 2023-04-27 | DNB MARKETS | Hold | Buy | Upgrade |
| 2023-04-03 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
| 2023-03-29 | DNB MARKETS | Hold | Buy | Upgrade |
| 2023-03-27 | HSBC | Hold | Buy | Upgrade |
| 2023-03-22 | BNP PARIBAS EXANE | Neutral | Outperform | Upgrade |
| 2023-01-27 | PARETO SECURITIES AS | Buy | Buy | Maintains |
| 2023-01-27 | BERENBERG | Buy | Hold | Downgrade |
| 2023-01-26 | PARETO SECURITIES AS | Buy | Buy | Maintains |
| 2022-11-28 | HSBC | Hold | Hold | Maintains |
| 2022-11-27 | HSBC | Hold | Hold | Maintains |
| 2022-10-28 | JYSKE BANK | Hold | Buy | Upgrade |
| 2022-10-28 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
| 2022-10-27 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
| 2022-10-27 | JYSKE BANK | Hold | Buy | Upgrade |
| 2022-05-27 | PARETO SECURITIES AS | Buy | Buy | Maintains |
| 2022-05-26 | PARETO SECURITIES AS | Buy | Buy | Maintains |
| 2022-03-30 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2022-03-29 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2021-12-22 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2021-12-21 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2021-12-06 | JYSKE BANK | Buy | Hold | Downgrade |
| 2021-12-05 | JYSKE BANK | Buy | Hold | Downgrade |
| 2021-08-25 | DNB MARKETS | Hold | Hold | Maintains |
| 2021-08-24 | DNB MARKETS | Hold | Hold | Maintains |
| 2021-04-20 | JYSKE BANK | Buy | Buy | Maintains |
| 2021-04-19 | JYSKE BANK | Buy | Buy | Maintains |
| 2021-01-28 | BERENBERG | Buy | Buy | Maintains |
| 2021-01-27 | BERENBERG | Buy | Buy | Maintains |
| 2021-01-01 | LIBERUM | Hold | Hold | Maintains |
| 2020-12-31 | LIBERUM | Hold | Hold | Maintains |
| 2024-07-23 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
| 2024-07-21 | DNB MARKETS | Buy | Buy | Maintains |
| 2024-05-26 | HSBC | Buy | Buy | Maintains |
| 2024-01-25 | JYSKE BANK | Buy | Buy | Maintains |
| 2023-10-30 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
| 2023-10-26 | DNB MARKETS | Buy | Buy | Maintains |
| 2023-10-16 | JYSKE BANK | Hold | Buy | Upgrade |
| 2024-12-16 | DNB MARKETS | Buy | Buy | Maintains |
| 2024-11-24 | HSBC | Buy | Buy | Maintains |
| 2024-11-03 | BNP PARIBAS EXANE | Neutral | Outperform | Upgrade |
| 2025-03-24 | HANDELSBANKEN CAPITAL MARKETS | Hold | Hold | Maintains |
| 2025-03-23 | HSBC | Buy | Buy | Maintains |
| 2025-03-20 | JEFFERIES | Hold | Hold | Maintains |
| 2025-01-22 | DNB MARKETS | Buy | Buy | Maintains |
| 2025-07-17 | HANDELSBANKEN CAPITAL MARKETS | Hold | Buy | Upgrade |
| 2025-07-16 | JEFFERIES | Hold | Hold | Maintains |
| 2025-05-25 | HSBC | Buy | Buy | Maintains |
| 2025-01-22 | DNB CARNEGIE | Buy | Buy | Maintains |
